PRTA
Prothena Corporation PLC
Price:  
12.79 
USD
Volume:  
710,913.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTA Relative Valuation

-244.6%
Upside

As of 2024-12-15, the Relative Valuation of Prothena Corporation PLC (PRTA) is (18.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.79 USD, the upside of Prothena Corporation PLC based on Relative Valuation is -244.6%.

The range of the Relative Valuation is (7.64) - (29.06) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 3.0x - 11.9x 7.4x
Forward P/E multiples 3.1x - 12.2x 7.6x
Fair Price (7.64) - (29.06) (18.50)
Upside -159.8% - -327.2% -244.6%
12.79 USD
Stock Price
(18.50) USD
Fair Price

PRTA Relative Valuation - Historical P/E Data

Date P/E
2024-12-13 -5.26
2024-12-12 -5.64
2024-12-11 -5.78
2024-12-10 -5.94
2024-12-09 -5.87
2024-12-06 -5.73
2024-12-05 -5.69
2024-12-04 -5.93
2024-12-03 -5.62
2024-12-02 -6.12
2024-11-29 -6.62
2024-11-27 -6.48
2024-11-26 -6.36
2024-11-25 -6.16
2024-11-22 -5.96
2024-11-21 -5.89
2024-11-20 -5.88
2024-11-19 -5.73
2024-11-18 -5.51
2024-11-15 -5.72
2024-11-14 -6.57
2024-11-13 -7.03
2024-11-12 -7.09
2024-11-11 -7.38
2024-11-08 -7.22
2024-11-07 -7.14
2024-11-06 -7.49
2024-11-05 -6.89
2024-11-04 -6.72
2024-11-01 -6.80
2024-10-31 -6.94
2024-10-30 -7.38
2024-10-29 -7.46
2024-10-28 -7.18
2024-10-25 -6.25
2024-10-24 -6.64
2024-10-23 -6.77
2024-10-22 -6.76
2024-10-21 -6.73
2024-10-18 -6.98
2024-10-17 -6.96
2024-10-16 -6.99
2024-10-15 -6.91
2024-10-14 -7.07
2024-10-11 -7.03
2024-10-10 -6.85
2024-10-09 -6.71
2024-10-08 -6.81
2024-10-07 -6.77
2024-10-04 -6.88